Anti-K-ras ribozyme induces growth inhibition and increased chemosensitivity in human colon cancer cells.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 495, doi. 10.1038/sj.cgt.7700125
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2000 AND VI 7 AND IP 3
Results: 17
1
2
Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 384, doi. 10.1038/sj.cgt.7700126
- By:
- Publication type:
- Article
3
Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c-myc specific ribozyme.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 407, doi. 10.1038/sj.cgt.7700127
- By:
- Publication type:
- Article
4
A prototype transduction tag system (ΔLNGFR/NGF) for noninvasive clinical gene therapy monitoring.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 430, doi. 10.1038/sj.cgt.7700123
- By:
- Publication type:
- Article
5
B-cell lymphoma idiotypes chimerized by gene targeting can induce tumor immunity.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 501, doi. 10.1038/sj.cgt.7700129
- By:
- Publication type:
- Article
6
SEREX analysis for tumor antigen identification in a mouse model of adenocarcinoma.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 446, doi. 10.1038/sj.cgt.7700124
- By:
- Publication type:
- Article
7
Gene therapy of metastatic colon carcinoma: Regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 438, doi. 10.1038/sj.cgt.7700131
- By:
- Publication type:
- Article
8
Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: Effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 413, doi. 10.1038/sj.cgt.7700132
- By:
- Publication type:
- Article
9
Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 373, doi. 10.1038/sj.cgt.7700136
- By:
- Publication type:
- Article
10
Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 456, doi. 10.1038/sj.cgt.7700137
- By:
- Publication type:
- Article
11
Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 486, doi. 10.1038/sj.cgt.7700140
- By:
- Publication type:
- Article
12
Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 422, doi. 10.1038/sj.cgt.7700141
- By:
- Publication type:
- Article
13
The cellular oncogene EWS/activating transcription factor 1 is unable to activate adenovirus-borne promoters: Implications for cytotoxic prodrug therapy of malignant melanoma of soft parts.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 396, doi. 10.1038/sj.cgt.7700142
- By:
- Publication type:
- Article
14
Activation of host antitumoral responses by cationic lipid/DNA complexes.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 353, doi. 10.1038/sj.cgt.7700143
- By:
- Publication type:
- Article
15
A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 466, doi. 10.1038/sj.cgt.7700145
- By:
- Publication type:
- Article
16
Construction and function of a recombinant adenovirus encoding a human aquaporin 1-green fluorescent protein fusion product.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 476, doi. 10.1038/sj.cgt.7700146
- By:
- Publication type:
- Article
17
Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 3, p. 360, doi. 10.1038/sj.cgt.7700151
- By:
- Publication type:
- Article